back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-15 15:08 Tx date 2023-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2023-11-15 15:07 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-17 16:05 Tx date 2023-08-14 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-56,740 vol |
68,219 | |
| Filed 2023-03-21 18:35 Tx date 2023-03-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+50,000 vol |
124,959 | |
| Filed 2022-11-30 11:57 Tx date 2022-11-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+26,959 vol |
74,959 | |
| Filed 2022-09-22 16:11 Tx date 2022-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,295
+6,400 vol $1.14 each |
28,800 | |
| Filed 2022-09-22 16:11 Tx date 2022-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,535
+22,400 vol $1.14 each |
22,400 | |
| Filed 2022-09-22 16:11 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-05 16:06 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
48,000 | |
| Filed 2020-10-30 16:38 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2020-10-30 16:34 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-30 16:26 Tx date 2020-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$183,840
+48,000 vol $3.83 each |
48,000 | |
| Filed 2020-10-30 16:24 Tx date 2020-05-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Adelman, Michael David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|